Pulse Biosciences, Inc (PLSE): Price and Financial Metrics


Pulse Biosciences, Inc (PLSE)

Today's Latest Price: $17.35 USD

0.95 (-5.19%)

Updated Dec 3 12:55pm

Add PLSE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

PLSE Stock Price Chart Interactive Chart >

Price chart for PLSE

PLSE Price/Volume Stats

Current price $17.35 52-week high $19.70
Prev. close $18.30 52-week low $5.11
Day low $17.11 Volume 65,111
Day high $18.49 Avg. volume 105,534
50-day MA $13.86 Dividend yield N/A
200-day MA $10.38 Market Cap 439.68M

Pulse Biosciences, Inc (PLSE) Company Bio


Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.


PLSE Latest News Stream


Event/Time News Detail
Loading, please wait...

PLSE Latest Social Stream


Loading social stream, please wait...

View Full PLSE Social Stream

Latest PLSE News From Around the Web

Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.

Mixed shelf roundup - healthcare

The following healthcare companies have filed for mixed shelf offerings:Pulse Biosciences (PLSE): $250M.ContraFect (CFRX): $150M.Larimar Therapeutics (LRMR): $200M....

Seeking Alpha | August 15, 2020

Nano-Pulse Stimulation™ Technology Produces Favorable Results in Several Clinical Studies Presented at the 2020 Laser Medicine and Surgery Virtual Annual Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS™) technology, today announced that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS). The virtual meeting went live on the ASLMS website on June 30, 2020. The clinical studies span the Company’s investigational use of NPS non-thermal energy in Nodular Basal Cell Carcinoma (BCC), Sebaceous Hyperplasia (SH) Lesions and Cutaneous Non-Genital Warts, along with e-Posters on pre-clinical observations of the effect of NPS energy on Murine Melanoma and Liver Tumors in situ.

Yahoo | July 1, 2020

Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company, announced today the closing of its oversubscribed rights offering and the final results thereof.

Yahoo | June 17, 2020

Pulse Biosciences, Inc. Announces Further Details of Oversubscribed Rights Offering

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company, announced today further details of its rights offering, which expired on June 8, 2020.

Yahoo | June 10, 2020

Pulse Biosciences, Inc. Announces Preliminary Results for Its Oversubscribed Rights Offering

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company, today announced preliminary results of its rights offering, which expired at 5:00 p.m. Eastern Time on June 8, 2020 (the "Expiration Date").

Yahoo | June 8, 2020

Read More 'PLSE' Stories Here

PLSE Price Returns

1-mo 39.13%
3-mo 87.16%
6-mo 101.51%
1-year 24.73%
3-year -21.21%
5-year N/A
YTD 29.38%
2019 17.02%
2018 -51.44%
2017 263.08%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9043 seconds.